Pacira Pharmaceuticals's total assets for Q3 2024 were $1.52B, a decrease of -7.60% from the previous quarter. PCRX total liabilities were $772.11M for the fiscal quarter, a 0.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.